Charles Brigden
Vorstandsvorsitzender bei Eliptica Ltd.
Profil
Mr. Charles Brigden is Senior Vice President & Head-Business Development at BTG Plc.
He received his MBA from Columbia Business School.
Aktive Positionen von Charles Brigden
Unternehmen | Position | Beginn |
---|---|---|
Eliptica Ltd.
Eliptica Ltd. Miscellaneous Commercial ServicesCommercial Services Eliptica Ltd. is a British company that specializes in research and experimental development on biotechnology. The private company was founded in 2022 by Markus Ralser, Aleksej Zelezniak, Charles Brigden. Charles Brigden has been the CEO since 2022. | Vorstandsvorsitzender | 01.04.2022 |
Ehemalige bekannte Positionen von Charles Brigden
Unternehmen | Position | Ende |
---|---|---|
BTG | Corporate Officer/Principal | - |
Ausbildung von Charles Brigden
Columbia Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
BTG Ltd.
BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
Eliptica Ltd.
Eliptica Ltd. Miscellaneous Commercial ServicesCommercial Services Eliptica Ltd. is a British company that specializes in research and experimental development on biotechnology. The private company was founded in 2022 by Markus Ralser, Aleksej Zelezniak, Charles Brigden. Charles Brigden has been the CEO since 2022. | Commercial Services |